The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft

MeSH terms

• Cytogenetic Analysis
• Graft vs Host Disease*
• Hematopoietic Stem Cell Transplantation*
• Humans
• Leukemia, Myeloid, Acute* / genetics
• Leukemia, Myeloid, Acute* / therapy
• Prognosis
• Retrospective Studies
• Risk Factors
• T-Lymphocytes